influenza vaccine (Novavax)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinfluenza vaccine (Novavax)
Drug Alias NameNovasome-adjuvanted Fluogen (Novavax)Fluogen (Novavax)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParkedale Pharmaceuticals, IncNovavax Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A